Wendy Luftig

Wendy Luftig is a seasoned health care attorney with experience in a variety of sectors, including industry, non-profit academic medical centers, and legal entities. She is currently a Senior Manager in the Global Drug Development unit at Novartis Pharmaceuticals Corporation, where she oversees a portfolio of legal documentation related to medical research for complex, multi-site clinical trials. In this capacity, she advises on challenging negotiation impasses, intellectual property issues, and privacy law concerns, as well as implements key legal and compliance initiatives.

Prior to assuming an industry role, Ms. Luftig worked in the Office of Science and Research at NYU Langone Medical Center negotiating transactional agreements with pharmaceutical companies, private foundations, and governmental entities, such as the NIH and CDC. Earlier in her career, she practiced as a corporate litigator at several major New York firms, including Dewey Ballantine.

Ms. Luftig is a former Chair of the Bioethical issues Committee of the New York City Bar Association and a recipient of the 2012 Jeremy Epstein Award for pro bono service for her work representing cancer patients through the Cancer Advocacy Project of the City Bar Justice Center. She has published in the areas of bioethics and organ transplantation.

Since 2015, she has served as an Adjunct Law Professor at Fordham Law School, teaching seminars in Health Care Policy & the Law and Pharmaceutical Law.

Ms. Luftig received her J.D. from Columbia University School of Law, where she was a Harlan Fiske Stone Scholar, has done graduate work in bioethics at Columbia University and holds an undergraduate degree from Hamilton College.